Dornase alfa (Dnase) drug data and news

Dornase alfa (Dnase) drug data, resources, and news articles (when available). Onconews.org provides news on cancer research. This section, which includes profiles on medicines that may or not be cancer-related is in beta form. If things run smoothly we will be releasing a new format late in the summer of 2006.

Generic name Dornase alfa (Dnase)
Brand Names/Synonyms Deoxyribonuclease-1 precursor;Deoxyribonuclease I;DNase I;Dornase alfa; Pulmozyme (Genentech Inc); Dilor; Dilor-400; Lufyllin; Lufyllin-400; Neothylline
Indication For treatment of cystic fibrosis
Sponsored links
Description Recombinant human deoxyribonuclease I. Delivered by aerosol mist. The protein is produced by genetically engineered Chinese Hamster Ovary (CHO) cells containing DNA encoding for the native human protein, deoxyribonuclease I (DNase). 260 residues
Pharmacology cystic fibrosis (CF) is a disease characterized by the retention of viscous purulent secretions in the airways. These thick secretions contribute both to reduced pulmonary function and to frequent pulmonary infection. Purulent pulmonary secretions contain very high concentrations of extracellular DNA released by degenerating leukocytes that accumulate in response to these infections. Pulmozyme hydrolyzes the DNA in sputum of CF patients and reduces sputum viscoelasticity.
Mechanism Of Action Pulmozyme hydrolyzes DNA, thereby degrading large, viscous DNA molecules into small, soluble fragments that are easily cleared from the lungs.
Dornase alfa (Dnase) News
(When available)
[an error occurred while processing this directive]
Dosage Forms SOLUTION
Drug_Category Enzyme replacement; enzymes (44:00.00)
Absorption Not Available
Interactions Not Available
Toxicity Not Available
Organisms Affected Humans and other mammals
Chemical IUPAC Name Human deoxyribonuclease I
Chemical Formula C1321H1999N339O396S9
Molecular Weight 29253.9
Smiles String Not Available
Melting Point 67 oC (Chan, H.K. et al., Pharm Res. 13:756-761 (1996))
Water Solubility Not Available
State Transparent, slightly viscous, aqueous liquid
LogP/Hphobicity -0.083
Isoelectric Point 4.58
Biotransformation Not Available
Half Life Not Available
Protein Binding [%] Not Available
RxList Link RXlist
Sponsored links
Drug Reference http://www.rxlist.com/cgi/generic3/pulmozyme.htm
Drug Type Approved Drug
Accession No BIOD00001
CAS Registry Number 9003-98-9
KEGG Compound ID Not Available
PubChem ID Not Available
PharmGKB ID PA10318
SwissProt ID DNAS1_HUMAN (P24855)
GenBank ID M55983
Drug ID Number [DIN] 2046733

Home | About | Cancers | Treatment | Medications
Copyright onconews.org 2005.
All Rights Reserved.
Google
 
Web onconews.org